If you spend more for something, you expect better quality, right? According to the Commonwealth Fund’s latest view of Medicare spending per capita vs. overall quality score, the data says otherwise for many states.
Eliza’s thought leaders weigh in on the latest developments from Eliza, our clients, and the healthcare industry at large.
King vs. Burwell expected to be decided this week. It may be true that many Americans have paid little attention to King v. Burwell as it has been discussed this spring by the Supreme Court.
With the Supreme Court announcing a decision as early as today in the King vs. Burwell debate, the theories, contingency plans, and financial scenarios are all a buzz on social media and news channels. Here are five of the most interesting posts and possible scenarios posted this month-
Despite it not being its own agenda item, the topic of King v. Burwell is being discussed over coffee, in the exhibit hall, and during Q&A sessions at AHIP Institute 2015. Here are the top 3 items to know about King v. Burwell and the impact on millions of Americans:
CMS recently released the long-awaited proposed regulations governing Medicaid managed care. The last time regulations were issued that address Medicaid managed care was over 10 years ago. Needless to say, a lot has changed in the market since, making it important for CMS to implement new and updated rules.
The age of the quantified self, or the idea that more individual data will lead to better and less expensive healthcare, is continuing to emerge.
In my role at Eliza, I'm focused on measuring the impact of interventions on member populations. Additionally, it is important for me to keep an eye on influencers of health care consumer experience as well as population health.
King vs. Burwell is certainly top of mind among colleagues and clients. A ruling from the Supreme Court is expected by end of June. Over 6 million U.S. citizens in 34 states are at risk of losing tax credits.
Elizabeth Holmes, who is the opening keynote at this week’s AHIP Institute, founded Theranos in 2003 with the mission to make actionable health information accessible to people everywhere at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live.